ロード中...
A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease
INTRODUCTION: Because of its genetic underpinnings and consistent age of onset within families, autosomal dominant Alzheimer’s disease (ADAD) provides a unique opportunity to conduct clinical trials of investigational agents as preventative or symptom-delaying treatments. The design of such trials m...
保存先:
| 出版年: | Alzheimers Res Ther |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4511231/ https://ncbi.nlm.nih.gov/pubmed/26203303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-015-0135-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|